- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Cell Biology
Volume 2012 (2012), Article ID 219196, 8 pages
Alterations in Cell-Extracellular Matrix Interactions during Progression of Cancers
1Department of Biochemistry, Acharya Nagarjuna University, Guntur 522510, India
2Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research (CSIR), Uppal Road, Hyderabad 500 007, India
Received 3 August 2011; Revised 13 October 2011; Accepted 14 October 2011
Academic Editor: Jun Chung
Copyright © 2012 Rajeswari Jinka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. Tian, S. Olson, J. M. Whitacre, and A. Harding, “The origins of cancer robustness and evolvability,” Integrative Biology, vol. 3, no. 1, pp. 17–30, 2011.
- D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011.
- C. Coghlin and G. I. Murray, “Current and emerging concepts in tumour metastasis,” Journal of Pathology, vol. 222, no. 1, pp. 1–15, 2010.
- C. M. Nelson and M. J. Bissell, “Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation,” Seminars in Cancer Biology, vol. 15, no. 5, pp. 342–352, 2005.
- J. Rajeswari, R. Kapoor, S. Pavuluri et al., “Differential gene expression and clonal selection during cellular transformation induced by adhesion deprivation,” BMC Cell Biology, vol. 11, article 93, pp. 1–13, 2010.
- S. Shen, J. Fan, B. Cai et al., “Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo,” Experimental Physiology, vol. 95, no. 2, pp. 369–379, 2010.
- E. E. Conway, “Central nervous system findings and intussusception: how are they related?” Pediatric Emergency Care, vol. 9, no. 1, pp. 15–18, 1993.
- J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006.
- S. Kumar and V. M. Weaver, “Mechanics, malignancy, and metastasis: the force journey of a tumor cell,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 113–127, 2009.
- R. Rathinam and S. K. Alahari, “Important role of integrins in the cancer biology,” Cancer and Metastasis Reviews, vol. 29, no. 1, pp. 223–237, 2010.
- H. Hutter, B. E. Vogel, J. D. Plenefisch et al., “Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes,” Science, vol. 287, no. 5455, pp. 989–1010, 2000.
- D. E. Ingber, J. A. Madri, and J. D. Jamieson, “Role of basal lamina in neoplastic disorganization of tissue architecture,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 6 I, pp. 3901–3905, 1981.
- S. C. Wittelsberger, K. Kleene, and S. Penman, “Progressive loss of shape-responsive metabolic controls in cells with increasingly transformed phenotype,” Cell, vol. 24, no. 3, pp. 859–866, 1981.
- H.-G. Zhang and W. E. Grizzle, “Exosomes and cancer: a newly described pathway of immune suppression,” Clinical Cancer Research, vol. 17, no. 5, pp. 959–964, 2011.
- Q. Chen, C. D. Manning, H. Millar et al., “CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells,” Clinical and Experimental Metastasis, vol. 25, no. 2, pp. 139–148, 2008.
- D. Barkan, J. E. Green, and A. F. Chambers, “Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth,” European Journal of Cancer, vol. 46, no. 7, pp. 1181–1188, 2010.
- R. K. Assoian and E. A. Klein, “Growth control by intracellular tension and extracellular stiffness,” Trends in Cell Biology, vol. 18, no. 7, pp. 347–352, 2008.
- N. Zahir, J. N. Lakins, A. Russell et al., “Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors,” Journal of Cell Biology, vol. 163, no. 6, pp. 1397–1407, 2003.
- T. Gudjonsson, L. Rønnov-Jessen, R. Villadsen, F. Rank, M. J. Bissell, and O. W. Petersen, “Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition,” Journal of Cell Science, vol. 115, no. 1, pp. 39–50, 2002.
- A. Beliveau, J. D. Mott, A. Lo et al., “Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo,” Genes and Development, vol. 24, no. 24, pp. 2800–2811, 2010.
- R. Pytela, M. D. Pierschbacher, and E. Ruoslahti, “Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor,” Cell, vol. 40, no. 1, pp. 191–198, 1985.
- R. O. Hynes, “Integrins: versatility, modulation, and signaling in cell adhesion,” Cell, vol. 69, no. 1, pp. 11–25, 1992.
- J. S. Desgrosellier and D. A. Cheresh, “Integrins in cancer: biological implications and therapeutic opportunities,” Nature Reviews Cancer, vol. 10, no. 1, pp. 9–22, 2010.
- A. E. Aplin, A. K. Howe, and R. L. Juliano, “Cell adhesion molecules, signal transduction and cell growth,” Current Opinion in Cell Biology, vol. 11, no. 6, pp. 737–744, 1999.
- D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh, “Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins,” Journal of Cell Biology, vol. 155, no. 4, pp. 459–470, 2001.
- J. Rajeswari and G. Pande, “The significance of α5β1 integrin dependent and independent actin cytoskelton organization in cell transformation and survival,” Cell Biology International, vol. 26, no. 12, pp. 1043–1055, 2002.
- R. Zaidel-Bar and B. Geiger, “The switchable integrin adhesome,” Journal of Cell Science, vol. 123, no. 9, pp. 1385–1388, 2010.
- S. Han, F. R. Khuri, and J. Roman, “Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways,” Cancer Research, vol. 66, no. 1, pp. 315–323, 2006.
- A. Kren, V. Baeriswyl, F. Lehembre et al., “Increased tumor cell dissemination and cellular senescence in the absence of β1-integrin function,” EMBO Journal, vol. 26, no. 12, pp. 2832–2842, 2007.
- M. Zöller, “Tetraspanins: push and pull in suppressing and promoting metastasis,” Nature Reviews Cancer, vol. 9, no. 1, pp. 40–55, 2009.
- D. Ribatti, “The contribution of Harold F. Dvorak to the study of tumor angiogenesis and stroma generation mechanisms,” Endothelium, vol. 14, no. 3, pp. 131–135, 2007.
- P. C. Brooks, R. A. F. Clark, and D. A. Cheresh, “Requirement of vascular integrin αvβ3 for angiogenesis,” Science, vol. 264, no. 5158, pp. 569–571, 1994.
- P. C. Brooks, S. Strömblad, L. C. Sanders et al., “Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3,” Cell, vol. 85, no. 5, pp. 683–693, 1996.
- E. I. Deryugina, M. A. Bourdon, G. X. Luo, R. A. Reisfeld, and A. Strongin, “Matrix metalloproteinase-2 activation modulates glioma cell migration,” Journal of Cell Science, vol. 110, no. 19, pp. 2473–2482, 1997.
- M. Kielosto, P. Nummela, K. Järvinen, M. Yin, and E. Hölttä, “Identification of integrins α6 and β7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells,” International Journal of Cancer, vol. 125, no. 5, pp. 1065–1073, 2009.
- Y. He, X. D. Liu, Z. Y. Chen et al., “Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis,” Clinical Cancer Research, vol. 13, no. 11, pp. 3115–3124, 2007.
- I. S. Vizirianakis, C. C. Yao, Y. Chen, B. L. Ziober, A. S. Tsiftsoglou, and R. H. Kramer, “Transfection of MCF-7 carcinoma cells with human integrin α7 cDNA promotes adhesion to laminin,” Archives of Biochemistry and Biophysics, vol. 385, no. 1, pp. 108–116, 2001.
- I. Staniszewska, E. M. Walsh, V. L. Rothman et al., “Effect of VP12 and viperistatin on inhibition of collagen receptors-dependent melanoma metastasis,” Cancer Biology and Therapy, vol. 8, no. 15, pp. 1507–1516, 2009.
- S. Van Slambrouck, C. Grijelmo, O. De Wever et al., “Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by α1-integrins during colon cancer cell invasion,” International Journal of Oncology, vol. 31, no. 6, pp. 1501–1508, 2007.
- M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann, “Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9482–9487, 2003.
- J. Huang, R. Roth, J. E. Heuser, and J. E. Sadler, “Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress,” Blood, vol. 113, no. 7, pp. 1589–1597, 2009.
- G. Y. Yang, K. S. Xu, Z. Q. Pan et al., “Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver,” Cancer Science, vol. 99, no. 5, pp. 879–887, 2008.
- S. K. Gupta and N. E. Vlahakis, “Integrin α9β1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase,” Journal of Cell Science, vol. 122, no. 12, pp. 2043–2054, 2009.
- N. Gomes, C. Legrand, and F. Fauvel-Lafève, “Shear stress induced release of von Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion,” Clinical and Experimental Metastasis, vol. 22, no. 3, pp. 215–223, 2005.
- I. Gil-Bazo, V. Catalán, J. Páramo et al., “Von Willebrand factor as an intermediate between hemostasis and angiogenesis of tumor origin,” Revista de Medicina de la Universidad de Navarra, vol. 47, no. 3, pp. 22–28, 2003.
- J. Roman, J. D. Ritzenthaler, S. Roser-Page, X. Sun, and S. Han, “α5β1-integrin expression is essential for tumor progression in experimental lung cancer,” American Journal of Respiratory Cell and Molecular Biology, vol. 43, no. 6, pp. 684–691, 2010.
- G. Maity, S. Fahreen, A. Banerji et al., “Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa),” Molecular and Cellular Biochemistry, vol. 336, no. 1-2, pp. 65–74, 2010.
- F. Mitelman and S. Heim, Cancer Cytogenetics, John Wiley & Sons, Chichester, UK, 2009.
- B. J. M. Braakhuis, C. R. Leemans, and R. H. Brakenhoff, “A genetic progression model of oral cancer: current evidence and clinical implications,” Journal of Oral Pathology and Medicine, vol. 33, no. 6, pp. 317–322, 2004.
- P. L. Martin, Q. Jiao, J. Cornacoff et al., “Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-αv integrin monoclonal antibody, despite widespread tissue binding,” Clinical Cancer Research, vol. 11, no. 19 I, pp. 6959–6965, 2005.
- N. J. Quintyne, J. E. Reing, D. R. Hoffelder, S. M. Gollin, and W. S. Saunders, “Spindle multipolarity is prevented by centrosomal clustering,” Science, vol. 307, no. 5706, pp. 127–129, 2005.
- X. Huang, T. E. Godfrey, W. E. Gooding, K. S. McCarty Jr., and S. M. Gollin, “Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma,” Genes Chromosomes and Cancer, vol. 45, no. 11, pp. 1058–1069, 2006.
- S. Kalyankrishna and J. R. Grandis, “Epidermal growth factor receptor biology in head and neck cancer,” Journal of Clinical Oncology, vol. 24, no. 17, pp. 2666–2672, 2006.
- B. Jahrsdörfer, J. E. Wooldridge, S. E. Blackwell, C. M. Taylor, B. K. Link, and G. J. Weiner, “Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity,” Leukemia, vol. 19, no. 5, pp. 759–766, 2005.
- Beverly A. Teicher, Cancer Drug Discovery and Development, vol. 14, 2nd edition, 2011.
- M. A. Cifone and I. J. Fidler, “Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 2, pp. 1039–1043, 1980.
- D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000.
- E. R. Lawlor, C. Scheel, J. Irving, and P. H. B. Sorensen, “Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors,” Oncogene, vol. 21, no. 2, pp. 307–318, 2002.
- A. Aparna and A. V. Judith, “Integrins in cancer,progression and therapy,” Science & Medicine, vol. 10, no. 2, pp. 84–96, 2005.
- P. C. Brooks, S. Stromblad, R. Klemke, D. Visscher, F. H. Sarkar, and D. A. Cheresh, “Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin,” Journal of Clinical Investigation, vol. 96, no. 4, pp. 1815–1822, 1995.
- J. W. Smith, Z. M. Ruggeri, T. J. Kunicki, and D. A. Cheresh, “Interaction of integrins αvβ3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites,” Journal of Biological Chemistry, vol. 265, no. 21, pp. 12267–12271, 1990.
- V. Bhaskar, D. Zhang, M. Fox et al., “A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo,” Journal of Translational Medicine, vol. 5, article 61, 2007.
- M. Millard, S. Odde, and N. Neamati, “Integrin targeted therapeutics,” Theranostics, vol. 1, pp. 154–188, 2011.
- O. Stoeltzing, W. Liu, N. Reinmuth et al., “Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-fu infusion reduces colorectal liver metastases and improves survival in mice,” International Journal of Cancer, vol. 104, no. 4, pp. 496–503, 2003.
- D. L. Livant, R. K. Brabec, K. J. Pienta et al., “Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma,” Cancer Research, vol. 60, no. 2, pp. 309–320, 2000.
- J. H. Kim, Y. S. Kim, K. Park et al., “Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy,” Biomaterials, vol. 29, no. 12, pp. 1920–1930, 2008.
- M. K. Yu, J. Park, Y. Y. Jeong, W. K. Moon, and S. Jon, “Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery,” Nanotechnology, vol. 21, no. 41, Article ID 415102, 2010.